Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early-Stage Breast Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07398118
What this trial is testing

CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer.

Who this might be right for
Breast Cancer Stage IBreast Cancer Early Stage Breast Cancer (Stage 1-3)
St. Antonius Hospital 61
Large-scale testing (Phase 3)Study completedNCT01940497
What this trial is testing

The Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 240
Testing effectiveness (Phase 2)UnknownNCT00415285
What this trial is testing

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Who this might be right for
Breast Neoplasms
Georgia Center for Oncology Research & Education 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06787118
What this trial is testing

Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III+2 more
Gustave Roussy, Cancer Campus, Grand Paris 130
Not applicableStudy completedNCT03069313
What this trial is testing

Vitamin B12 for Aromatase Inhibitors Musculoskeletal Symptoms

Who this might be right for
Relief of Joint Pain
Texas Tech University Health Sciences Center, El Paso 41
Not applicableStudy completedNCT00897884
What this trial is testing

Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Mount Sinai Hospital, Canada 39
Not applicableUnknownNCT03797248
What this trial is testing

Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer

Who this might be right for
Early-stage Breast Cancer
Chang Gung Memorial Hospital 310
Not applicableStudy completedNCT05730010
What this trial is testing

Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis

Who this might be right for
Triple Negative Breast Cancer
Indiana University 289
Not applicableEnded earlyNCT05560685
What this trial is testing

SMART-ER: Symptom Monitoring With Patient-reported Outcomes

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07246317
What this trial is testing

Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 188
Not applicableStudy completedNCT03886389
What this trial is testing

Breast Cancer Diet Intervention Study

Who this might be right for
Early-stage Breast CancerCarbohydrate EngorgementProliferation+2 more
Helse Stavanger HF 80
Large-scale testing (Phase 3)Study completedNCT00130533
What this trial is testing

Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 876
Testing effectiveness (Phase 2)Study completedNCT02132949
What this trial is testing

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 401
Not applicableStudy completedNCT02428114
What this trial is testing

A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 142
Testing effectiveness (Phase 2)UnknownNCT02617043
What this trial is testing

Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery

Who this might be right for
Breast Cancer
Fudan University 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07317778
What this trial is testing

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)HR Positive/HER2 Low Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 249
Large-scale testing (Phase 3)UnknownNCT00003678
What this trial is testing

Tamoxifen in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital Birmingham 20,000
Large-scale testing (Phase 3)UnknownNCT00070278
What this trial is testing

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Who this might be right for
Breast Cancer
Cambridge University Hospitals NHS Foundation Trust 800
Not applicableNot Yet RecruitingNCT06422949
What this trial is testing

Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy

Who this might be right for
Breast CancerNeuropathy;Peripheral
European Institute of Oncology 120
Not applicableStudy completedNCT05599334
What this trial is testing

A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib

Who this might be right for
Breast CancerAdjuvant TherapyHER2-positive Breast Cancer
Pierre Fabre Medicament 111
Next Page